An official website of the United States government
Home
Name
CVB
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CVB
Name
Alternate Names
Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017
Abbreviations
CCNU
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
079037
79037
Primary Site
Histology
None
Remarks
Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo
Abbreviations
BLE
BLEO
BLM
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
125066
Primary Site
Histology
None
Remarks
FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.
Coding
This drug should be coded
Name
Alternate Names
29060-LE
Alkaban
LE-29060
Velban
Velbe
Velsar
Vinblastine
Vinblastine sulfate
Abbreviations
VBL
VELB
VLB
Category
Chemotherapy
Subcategory
Plant alkaloid
NSC Number
049842
49842
Primary Site
None
Histology
None
Remarks
A cell cycle specific chemotherapeutic agent; vinca plant alkaloid; mitotic inhibitor. FDA approved uses in 3rd line breast cancer, choriocarcinoma, palliative in stages III and IV Hodgkin's lymphoma, Kaposi's sarcoma, mycosis fungoides, palliative in non-Hodgkin's histiocytic/lymphocytic lymphoma, and advanced testicular carcinoma.
Coding
This drug should be coded
